ASND CIK: 1612042

Ascendis Pharma A/S

  • Denmark
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
4.26
FY22:
39.0
FY23:
222
FY24:
319
FY25:
625
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−452
FY22:
−562
FY23:
−456
FY24:
−279
FY25:
−136
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−424
FY22:
−554
FY23:
−438
FY24:
–
FY25:
−66.5
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−384
FY22:
−578
FY23:
−474
FY24:
−373
FY25:
−213
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−384
FY22:
−583
FY23:
−481
FY24:
−378
FY25:
−228

All amounts in millions EUR Data sources:SEC EDGARTwelve Data